ALPS Group Inc Ordinary Share (NASDAQ:ALPS) Sees Significant Decline in Short Interest

Posted by ABMN Staff on May 28th, 2026

ALPS Group Inc Ordinary Share (NASDAQ:ALPS – Get Free Report) was the recipient of a large decline in short interest in the month of May. As of May 15th, there was short interest totaling 5,804 shares, a decline of 82.5% from the April 30th total of 33,182 shares. Based on an average daily trading volume, of 29,325 shares, the short-interest ratio is currently 0.2 days. Approximately 0.0% of the company’s stock are short sold.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings assumed coverage on shares of ALPS Group Inc Ordinary Share in a research note on Wednesday, April 8th. They set a “sell (e+)” rating on the stock. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has a consensus rating of “Sell”.

View Our Latest Research Report on ALPS

ALPS Group Inc Ordinary Share Stock Up 1.6%

ALPS opened at $0.74 on Thursday. The stock has a market capitalization of $123.15 million, a PE ratio of 2.24 and a beta of -0.12. ALPS Group Inc Ordinary Share has a 1-year low of $0.56 and a 1-year high of $15.00.

About ALPS Group Inc Ordinary Share

(Get Free Report)

ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.